Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BCC Research | PRODUCT CODE: 1465620

Cover Image

PUBLISHER: BCC Research | PRODUCT CODE: 1465620

Global Skin Allergy Testing Market

PUBLISHED:
PAGES: 75 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5500
PDF (2-5 Users)
USD 6600
PDF (Site License)
USD 7920
PDF (Enterprise License)
USD 9504

Add to Cart

The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.

The global market for skin prick test is expected to grow from $489.3 million in 2023 to $678.6 million by 2028, at a CAGR of 6.8% from 2023 to 2028.

The global market for patch test is expected to grow from $40.1 million in 2023 to $54 million by 2028, at a CAGR of 6.1% from 2023 to 2028.

Report Scope

This report provides detailed information about the global skin allergy testing market. It includes market projections for 2028 and a ranking of key market players. It also analyzes the size of the skin allergy testing market based on test types, applications and end users. For this analysis, the skin allergy testing market is broken down by test type into the following segments: prick test, patch test, and intradermal test. It should be noted that this study excludes in vitro allergy tests. Based on applications, the skin allergy testing market is segmented into allergic rhinitis, allergic asthma, drug allergy, allergic conjunctivitis, anaphylaxis and others. Based on end users, the market is segmented into hospitals and clinics, diagnostic centers and others.

Report Includes

  • 28 data tables and 28 additional tables
  • An overview of the global market for skin allergy testing
  • Analysis of global market trends, featuring revenue data for 2020-2022, estimated figures for 2023, and forecasts for 2028. This analysis includes projected CAGRs through 2028
  • Evaluation of the current market size and revenue growth prospects specific to skin allergy testing, along with a market share analysis by test type, application, end user and region
  • Insights into R&D related to skin allergy testing and emerging technologies, as well as government regulations and mandates, and general economic trends
  • Discussion of how to overcome challenges related to commercialization
  • A look at ESG trends
  • Analysis of companies' market shares, proprietary technologies, alliances and patents
  • Profiles of the leading players
Product Code: MDS104A

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • PESTEL Analysis
  • Porter's Five Forces Analysis
  • Supply Chain Analysis

Chapter 3 Market Dynamics

  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Challenges

Chapter 4 Emerging Technologies and Developments

  • Emerging Technologies
  • Automated Skin Prick Test Devices
  • Digitalization
  • Artificial Intelligence
  • Clinical Trials Analysis
  • Clinical Trials Analysis, by Type of Study
  • Clinical Trials Analysis, by Status
  • Clinical Trials Analysis, by Phase
  • Selected Clinical Trials
  • Patent Analysis
  • Patents, by Year
  • Patents, by Top Applicant
  • Patents, by Top Owner
  • Patents, by Jurisdiction

Chapter 5 Market Segmentation Analysis

  • Segmentation Breakdown
  • Market Analysis, by Test Type
  • Skin Prick Test (SPT)
  • Patch Test
  • Intradermal Test
  • Market Analysis, by Application
  • Allergy Rhinitis
  • Allergic Asthma
  • Drug Allergy
  • Allergic Conjunctivitis
  • Anaphylaxis
  • Others
  • Market Analysis, by End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Other End Users
  • Geographic Breakdown
  • Market Analysis, by Region
  • Europe
  • North America
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Market Analysis
  • Top Players
  • Strategic Analysis

Chapter 7 Sustainability in Skin Allergy Testing: An ESG Perspective

  • Introduction to ESG
  • Sustainability in Skin Allergy Testing Industry: An ESG Perspective
  • Key ESG Issues
  • Skin Allergy Testing Industry: ESG Performance Analysis
  • Concluding Remarks from BCC

Chapter 8 Appendix

  • Methodology
  • Sources
  • Acronyms
  • Company Profiles
  • ALK-ABELLO A/S
  • ALL CURE PHARMA
  • ALLERGY THERAPEUTICS
  • CHEMOTECHNIQUE MB DIAGNOSTICS AB
  • DERMAPHARM HOLDING SE
  • HAL ALLERGY B.V.
  • JUBILANT PHARMOVA LTD.
  • LINCOLN DIAGNOSTICS INC.
  • SMARTPRACTICE.COM
  • STALLERGENES GREER
Product Code: MDS104A

List of Tables

  • Summary Table A : Global Market for Skin Allergy Testing, by Test Type, Through 2028
  • Summary Table B : Global Market for Skin Allergy Testing, by Region, Through 2028
  • Table 1 : Clinical Trials in Skin Allergy Testing, Based on Type of Study, as of February 2024
  • Table 2 : Clinical Trials in Skin Allergy Testing, Based on Their Status, as of February 2024
  • Table 3 : Clinical Trials in Skin Allergy Testing, Based on Phase, as of February 2024
  • Table 4 : Selected Clinical Trial in Skin Allergy Testing, by Sponsors
  • Table 5 : Patents Granted for Allergen Extracts, by Top Applicant, 2020-2023
  • Table 6 : Patents Granted for Allergen Extracts, by Top Owner, 2020-2023
  • Table 7 : Patents Granted for Allergen Extracts, by Jurisdiction, 2020-2023
  • Table 8 : Global Market for Skin Allergy Testing, by Test Type, Through 2028
  • Table 9 : Global Market for Skin Prick Test, by Region, Through 2028
  • Table 10 : Global Market for Patch Test, by Region, Through 2028
  • Table 11 : Global Market for Intradermal Test, by Region, Through 2028
  • Table 12 : Global Market for Skin Allergy Testing, by Application, Through 2028
  • Table 13 : Global Market for Allergy Rhinitis, by Region, Through 2028
  • Table 14 : Global Market for Allergic Asthma, by Region, Through 2028
  • Table 15 : Global Market for Drug Allergy, by Region, Through 2028
  • Table 16 : Global Market for Allergic Conjunctivitis, by Region, Through 2028
  • Table 17 : Global Market for Anaphylaxis, by Region, Through 2028
  • Table 18 : Global Market for Skin Allergy Testing for Other Conditions, by Region, Through 2028
  • Table 19 : Global Market for Skin Allergy Testing, by End User, Through 2028
  • Table 20 : Global Market for Hospital and Clinics, by Region, Through 2028
  • Table 21 : Global Market for Diagnostic Centers, by Region, Through 2028
  • Table 22 : Global Market for Other End Users, by Region, Through 2028
  • Table 23 : Global Market for Skin Allergy Testing, by Region, Through 2028
  • Table 24 : Skin Allergy Testing: Market Player Ranking
  • Table 25 : ESG Rankings for Skin Allergy Testing Companies, 2024*
  • Table 26 : ESG: Environmental Performance
  • Table 27 : ESG: Social Performance
  • Table 28 : ESG: Governance Performance
  • Table 29 : Glossary of Terms Used in Skin Allergy Testing Market
  • Table 30 : ALK-Abello A/S: Company Snapshot
  • Table 31 : ALK-Abello A/S: Financial Performance, FY 2022 and 2023
  • Table 32 : ALK-Abello A/S: Product Portfolio
  • Table 33 : ALK-Abello A/S: News/Key Developments, 2024
  • Table 34 : All Cure Pharma: Company Snapshot
  • Table 35 : All Cure Pharma: Product Portfolio
  • Table 36 : Allergy Therapeutics: Company Snapshot
  • Table 37 : Allergy Therapeutics: Financial Performance, FY 2022 and 2023
  • Table 38 : Allergy Therapeutics: Product Portfolio
  • Table 39 : Chemotechnique MB Diagnostics AB: Company Snapshot
  • Table 40 : Chemotechnique MB Diagnostics AB: Product Portfolio
  • Table 41 : Dermapharm Holding SE: Company Snapshot
  • Table 42 : Dermapharm Holding SE: Financial Performance, FY 2021 and 2022
  • Table 43 : Dermapharm Holding SE: Product Portfolio
  • Table 44 : HAL Allergy B.V.: Company Snapshot
  • Table 45 : HAL Allergy B.V.: Product Portfolio
  • Table 46 : Jubilant Pharmova Ltd.: Company Snapshot
  • Table 47 : Jubilant Pharmova Ltd.: Financial Performance, FY 2022 and 2023
  • Table 48 : Jubilant Pharmova Ltd.: Product Portfolio
  • Table 49 : Lincoln Diagnostics Inc.: Company Snapshot
  • Table 50 : Lincoln Diagnostics Inc.: Product Portfolio
  • Table 51 : SmartPractice.com: Company Snapshot
  • Table 52 : SmartPractice.com: Product Portfolio
  • Table 53 : Stallergenes Greer: Company Snapshot
  • Table 54 : Stallergenes Greer: Product Portfolio

List of Figures

  • Summary Figure A : Global Market for Skin Allergy Testing, by Test Type, 2020-2028
  • Summary Figure B : Global Market for Skin Allergy Testing, by Region, Through 2028
  • Figure 1 : Allergy Testing: Methods and Advantages
  • Figure 2 : Skin Allergy Testing Market: PESTEL Analysis
  • Figure 3 : Supply Chain Analysis of Allergens
  • Figure 4 : Market Dynamics of Skin Allergy Testing
  • Figure 5 : Emerging Trends/Technologies in the Skin Allergy Testing Market
  • Figure 6 : Patents Granted for Allergen Extracts, by Year, 2020-2023
  • Figure 7 : Global Market Shares for Skin Allergy Testing, by Test Type, 2022
  • Figure 8 : Global Market Shares for Skin Allergy Testing, by Application, 2022
  • Figure 9 : Global Market Shares for Skin Allergy Testing, by End User, 2022
  • Figure 10 : Global Market Shares for Skin Allergy Testing, by Region, 2022
  • Figure 11 : European Market for Skin Allergy Testing, 2020-2028
  • Figure 12 : North American Market for Skin Allergy Testing, 2020-2028
  • Figure 13 : Asia-Pacific Market for Skin Allergy Testing, 2020-2028
  • Figure 14 : Rest of the World Market for Skin Allergy Testing, 2020-2028
  • Figure 15 : ESG Pillars
  • Figure 16 : Advantages of ESG for Companies
  • Figure 17 : Breakdown of ESG Penetration in the Skin Allergy Testing Market, 2023
  • Figure 18 : Methodology Used in Skin Allergy Testing Market
  • Figure 19 : ALK-Abello A/S: Revenue Share, by Business Unit, FY 2023
  • Figure 20 : ALK-Abello A/S: Revenue Share, by Country/Region, FY 2023
  • Figure 21 : Allergy Therapeutics: Revenue Share, by Business Unit, FY 2023
  • Figure 22 : Allergy Therapeutics: Revenue Share, by Country/Region, FY 2023
  • Figure 23 : Dermapharm Holding SE: Revenue Share, by Business Unit, FY 2022
  • Figure 24 : Jubilant Pharmova Ltd.: Revenue Share, by Business Unit, FY 2023
  • Figure 25 : Jubilant Pharmova Ltd.: Revenue Share, by Country/Region, FY 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!